S. Kilic Et Al. , "Protection from cyclophosphamide-induced ovarian damage with bone marrow-derived mesenchymal stem cells during puberty," GYNECOLOGICAL ENDOCRINOLOGY , vol.30, no.2, pp.135-140, 2014
Kilic, S. Et Al. 2014. Protection from cyclophosphamide-induced ovarian damage with bone marrow-derived mesenchymal stem cells during puberty. GYNECOLOGICAL ENDOCRINOLOGY , vol.30, no.2 , 135-140.
Kilic, S., Pinarli, F., Ozogul, C., Tasdemir, N., Sarac, G. N., & Delibasi, T., (2014). Protection from cyclophosphamide-induced ovarian damage with bone marrow-derived mesenchymal stem cells during puberty. GYNECOLOGICAL ENDOCRINOLOGY , vol.30, no.2, 135-140.
Kilic, Sevtap Et Al. "Protection from cyclophosphamide-induced ovarian damage with bone marrow-derived mesenchymal stem cells during puberty," GYNECOLOGICAL ENDOCRINOLOGY , vol.30, no.2, 135-140, 2014
Kilic, Sevtap Et Al. "Protection from cyclophosphamide-induced ovarian damage with bone marrow-derived mesenchymal stem cells during puberty." GYNECOLOGICAL ENDOCRINOLOGY , vol.30, no.2, pp.135-140, 2014
Kilic, S. Et Al. (2014) . "Protection from cyclophosphamide-induced ovarian damage with bone marrow-derived mesenchymal stem cells during puberty." GYNECOLOGICAL ENDOCRINOLOGY , vol.30, no.2, pp.135-140.
@article{article, author={Sevtap Kilic Et Al. }, title={Protection from cyclophosphamide-induced ovarian damage with bone marrow-derived mesenchymal stem cells during puberty}, journal={GYNECOLOGICAL ENDOCRINOLOGY}, year=2014, pages={135-140} }